Comprehending the allergen repertoire of shrimp for precision molecular diagnosis of shrimp allergy.
DBPCFC
allergen profiling
component-resolved diagnosis
shellfish allergy
tropomyosin
Journal
Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
revised:
06
04
2022
received:
29
10
2021
accepted:
26
04
2022
pubmed:
15
5
2022
medline:
1
10
2022
entrez:
14
5
2022
Statut:
ppublish
Résumé
Clinical management of shrimp allergy is hampered by the lack of accurate tests. Molecular diagnosis has been shown to more accurately reflect the clinical reactivity but the full spectrum of shrimp allergens and their clinical relevance are yet to be established. We therefore sought to comprehend the allergen repertoire of shrimp, investigate and compare the sensitization pattern and diagnostic value of the allergens in allergic subjects of two distinct populations. Sera were collected from 85 subjects with challenge-proven or doctor-diagnosed shrimp allergy in Hong Kong and Thailand. The IgE-binding proteins of Penaeus monodon were probed by Western blotting and identified by mass spectrometry. Recombinant shrimp allergens were synthesized and analyzed for IgE sensitization by ELISA. Ten IgE-binding proteins were identified, and a comprehensive panel of 11 recombinant shrimp allergens was generated. The major shrimp allergens among Hong Kong subjects were troponin C (Pen m 6) and glycogen phosphorylase (Pen m 14, 47.1%), tropomyosin (Pen m 1, 41.2%) and sarcoplasmic-calcium binding protein (Pen m 4, 35.3%), while those among Thai subjects were Pen m 1 (68.8%), Pen m 6 (50.0%) and fatty acid-binding protein (Pen m 13, 37.5%). Component-based tests yielded significantly higher area under curve values (0.77-0.96) than shrimp extract-IgE test (0.70-0.75). Yet the best component test differed between populations; Pen m 1-IgE test added diagnostic value only in the Thai cohort, whereas sensitizations to other components were better predictors of shrimp allergy in Hong Kong patients. Pen m 14 was identified as a novel shrimp allergen predictive of challenge outcome. Molecular diagnosis better predicts shrimp allergy than conventional tests, but the relevant component is population dependent.
Sections du résumé
BACKGROUND
Clinical management of shrimp allergy is hampered by the lack of accurate tests. Molecular diagnosis has been shown to more accurately reflect the clinical reactivity but the full spectrum of shrimp allergens and their clinical relevance are yet to be established. We therefore sought to comprehend the allergen repertoire of shrimp, investigate and compare the sensitization pattern and diagnostic value of the allergens in allergic subjects of two distinct populations.
METHODS
Sera were collected from 85 subjects with challenge-proven or doctor-diagnosed shrimp allergy in Hong Kong and Thailand. The IgE-binding proteins of Penaeus monodon were probed by Western blotting and identified by mass spectrometry. Recombinant shrimp allergens were synthesized and analyzed for IgE sensitization by ELISA.
RESULTS
Ten IgE-binding proteins were identified, and a comprehensive panel of 11 recombinant shrimp allergens was generated. The major shrimp allergens among Hong Kong subjects were troponin C (Pen m 6) and glycogen phosphorylase (Pen m 14, 47.1%), tropomyosin (Pen m 1, 41.2%) and sarcoplasmic-calcium binding protein (Pen m 4, 35.3%), while those among Thai subjects were Pen m 1 (68.8%), Pen m 6 (50.0%) and fatty acid-binding protein (Pen m 13, 37.5%). Component-based tests yielded significantly higher area under curve values (0.77-0.96) than shrimp extract-IgE test (0.70-0.75). Yet the best component test differed between populations; Pen m 1-IgE test added diagnostic value only in the Thai cohort, whereas sensitizations to other components were better predictors of shrimp allergy in Hong Kong patients.
CONCLUSION
Pen m 14 was identified as a novel shrimp allergen predictive of challenge outcome. Molecular diagnosis better predicts shrimp allergy than conventional tests, but the relevant component is population dependent.
Identifiants
pubmed: 35567339
doi: 10.1111/all.15370
pmc: PMC9795902
doi:
Substances chimiques
Allergens
0
Fatty Acid-Binding Proteins
0
Tropomyosin
0
Troponin C
0
Immunoglobulin E
37341-29-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3041-3051Informations de copyright
© 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Références
Mol Immunol. 2018 Aug;100:28-57
pubmed: 29858102
J Allergy Clin Immunol Pract. 2020 Apr;8(4):1349-1358.e16
pubmed: 31857266
Pediatr Allergy Immunol. 2009 Jun;20(4):339-46
pubmed: 18808390
J Allergy Clin Immunol. 1994 Nov;94(5):882-90
pubmed: 7963157
J Allergy Clin Immunol. 2010 Aug;126(2):324-31, 331.e1-7
pubmed: 20624649
Allergy. 2011 Oct;66(10):1375-83
pubmed: 21651567
Mol Nutr Food Res. 2014 Sep;58(9):1915-25
pubmed: 24978201
Int Arch Allergy Immunol. 2017;174(2):86-96
pubmed: 29065408
Int J Mol Sci. 2020 Mar 23;21(6):
pubmed: 32210187
Int Arch Allergy Immunol. 2012;157(1):3-10
pubmed: 21894023
J Allergy Clin Immunol. 2013 Aug;132(2):393-9
pubmed: 23582909
J Allergy Clin Immunol Pract. 2020 Apr;8(4):1359-1370.e2
pubmed: 31917365
Allergy. 2022 Oct;77(10):3041-3051
pubmed: 35567339
J Allergy Clin Immunol. 2010 Jan;125(1):191-7.e1-13
pubmed: 20109746
Mol Immunol. 2011 Sep;48(15-16):1983-92
pubmed: 21784530
Ann Allergy Asthma Immunol. 2020 Sep;125(3):355-357
pubmed: 32544533
J Investig Allergol Clin Immunol. 2022 Dec 15;32(6):460-470
pubmed: 34489219
JAMA Netw Open. 2019 Jan 4;2(1):e185630
pubmed: 30646188
Clin Exp Allergy. 2015 Mar;45(3):687-97
pubmed: 25257922
Int J Mol Sci. 2020 Dec 22;22(1):
pubmed: 33375120
Pediatr Allergy Immunol. 2020 Oct;31(7):792-804
pubmed: 32323392
J Allergy Clin Immunol Pract. 2015 Jul-Aug;3(4):521-9.e10
pubmed: 25769902
J Proteome Res. 2013 Feb 1;12(2):808-20
pubmed: 23244200
Fish Shellfish Immunol. 2019 Aug;91:275-283
pubmed: 31125663
Methods Enzymol. 2009;463:191-222
pubmed: 19892174
Pediatr Allergy Immunol. 2013 Nov;24(7):665-70
pubmed: 24112427
Allergy. 2010 Mar;65(3):385-90
pubmed: 19889114
J Allergy Clin Immunol Pract. 2021 Jan;9(1):236-244.e9
pubmed: 32931950
PLoS One. 2014 Nov 03;9(11):e111649
pubmed: 25365343
Asian Pac J Allergy Immunol. 2015 Jun;33(2):136-42
pubmed: 26141035